A Phase 1, Open Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone.
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2017
At a glance
- Drugs Isavuconazonium (Primary) ; Ethinylestradiol/norethisterone
- Indications Aspergillosis; Candidiasis; Zygomycosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 13 Jul 2012 Actual end date (1 Jun 2012) as reported by ClinicalTrials.gov.
- 08 Jun 2012 Planned End Date changed from 1 May 2012 to 30 Jun 2012.
- 04 Jun 2012 Planned end date changed from 30 Jun 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.